Drug Profile
LY 2428757
Alternative Names: GLP-1-PEG; LY2428757; Pegylated GLP-1 analogue (LY2428757) - Eli LillyLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Developer Eli Lilly and Company; Transition Therapeutics
- Class Antihyperglycaemics; Glucagon-like peptides; Hormones
- Mechanism of Action Glucagon-like peptide 1 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 20 Jul 2010 Discontinued - Phase-I for Type-2 diabetes mellitus in Puerto Rico (SC)
- 20 Jul 2010 Discontinued - Phase-I for Type-2 diabetes mellitus in USA (SC)
- 20 Jul 2010 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (SC)